Harvard Club of Japan - Harvard University
Nov 10, 2022 · Japan is one of Moderna’s key markets with strategic investments with a recent visit Global CEO Stéphane Bancel and leadership team. President and Representative …
Rami Suzuki - Supporters | LINK-J
Representative Director and CEO, ARC Therapies Inc. Managing Director, ARCHIMED GROUP After obtaining a Ph.D. in medicine from University College London in 1999 and subsequent …
Patent rights jointly owned by the National Cancer Center and the ...
Jul 11, 2024 · Rami Suzuki, CEO of ARC Therapies Inc., commented: "We are committed to the research and development of the CCR4 CAR-T cell therapy licensed from the National Cancer …
DE&I and leadership at Moderna Japan: An interview with Rami Suzuki ...
Moderna Japan’s president and representative director Rami Suzuki shares what diversity means to her and her career advice for young women professionals.
鈴木 蘭美 | サポーター紹介 | LINK-J
2020 年よりフェリング・ファーマ株式会社の CEO Japan 代表取締役を務め、 2021 年から 2023 年末までモデルナ・ジャパン株式会社の代表取締役社長。 2024 年 1 月から現職。 マ …
Rami Suzuki - Monex Group | LinkedIn
Monex Group · UCL · 東京都 · LinkedInのつながり500人以上。10億人のメンバーを擁するプロフェッショナルコミュニティであるLinkedInでRami Suzukiさんのプロフィールを閲覧しま …
- Location: Monex Group
Rami Suzuki Profile: Contact Information & Network - PitchBook
Information on current and former positions, network members and contacts for Rami Suzuki. Use the PitchBook Platform to explore the full profile.
[Live] Moderna Mindsets - Rami Suzuki, President, Moderna Japan
Jul 7, 2022 · In this event organized by RGF Executive Search Japan, we bring you the latest insights and best practices to build transformational teams from our guest speaker, Rami …
#71 Rami Suzuki 鈴木蘭美 - Celebrating Women in Japan
Dr Rami Suzuki currently heads up Business Development and Medical Affairs of Janssen, Pharmaceutical Companies of Johnson & Johnson. With a PhD in Medicine, her mission is to …
Moderna Japan Chief to Bow Out at Year-End for Personal Reasons
Aug 14, 2023 · Moderna Japan said on August 10 that President Rami Suzuki will resign as of December 31 for “personal reasons.” Michael Azrak, general manager of Moderna Australia, …